Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumoniaRoxane Rohani, Sydney M. Hyder, Hiam Abdala‐Valencia et al.|Journal of Antimicrobial Chemotherapy|2022Cited by 4
Transitions in lung microbiota landscape associate with distinct patterns of pneumonia progressionJack T. Sumner, Joseph I. Bailey, Estefani Diaz et al.|Cell Host & Microbe|2025Cited by 3
Large language models accurately identify immunosuppression in intensive care unit patientsVijeeth Guggilla, Erin Korth, Amy Ludwig et al.|Journal of the American Medical Informatics Association|2025Cited by 1